Study analyzes opioid overdose risk during and after pregnancy among Massachusetts women

July 11, 2018, Massachusetts General Hospital
Credit: CC0 Public Domain

A study of women giving birth in Massachusetts found a higher level of opioid use disorder than have studies conducted in other states. In a paper published in the journal Obstetrics & Gynecology, the research team—consisting of investigators from the Mass. Department of Public Health (DPH) and several academic medical centers, led by a MassGeneral Hospital for Children (MGHfC) physician—found that opioid overdose events decreased during pregnancy, reaching their lowest level during the third trimester, but then increased during the postpartum period, becoming significantly higher during the second six months after delivery.

"Our findings suggest we need to develop extended and long-term services to support women and families impacted by substance use disorder," says Davida Schiff, MD, MSc, an MGHfC pediatrician and the lead and corresponding author of the paper. "We need additional research to determine the best ways to improve retention in treatment and adherence to medication therapy after delivery, and we need to enhance our medical and infrastructure to provide support to women in achieving long-term recovery."

With the increasing levels of opioid-use disorder across the U.S., have quadrupled over the past 15 years, the authors note. In many states, opioid overdoses have been cited as major contributors to pregnancy-associated deaths. Estimates of opioid use disorder among pregnant women have ranged from 0.4 to 0.8 percent, and estimates for all women of reproductive age up to 2 percent. But pregnancy often serves as motivation for women to enter treatment for substance use, the standard of which is behavioral therapy combined with medications like methadone or buprenorphine.

While discontinuing medication therapy increases risks of relapse and , there has been little data available on either the timing of overdose events or the relationship of medication therapy to relapse during pregnancy and after delivery. To explore those factors, along with assessing characteristics of women with opioid use disorder who gave birth in Massachusetts, the team took advantage of a Department of Public Health dataset developed in response to a 2015 mandate from the state legislature.

"This unique dataset—which links statewide resources including hospital discharge data, ambulance trip records, birth and death certificates, and addiction treatment data—combines a rich array of data sources and illustrates multiple factors contributing to overdose, particularly the impact of receiving medication treatment with methadone or buprenorphine," says co-author Dana Bernson, MPH, of the Mass. DPH. "Additionally we were able to include non-fatal overdose events that required medical attention, while other states have only reported overdose deaths."

From the dataset that included almost 178,000 deliveries of a live infant of 20 weeks or greater gestational age to Massachusetts resident women between Jan. 1, 2012 and Sept. 30, 2014, the research team identified 4,154 deliveries to women who had some evidence of an opioid use disorder in the year before delivery. While the 2.3 percent prevalence of opioid use disorder is more than double that reported in other states, the comprehensive dataset may have given a more accurate reflection of the level of opioid use disorder than previous studies have provided.

Among all women in the dataset, 184 experienced an opioid overdose event—defined as either admission to a health care facility for overdose treatment or a death certificate listing opioid overdose as the cause of death—during the year before or after delivery. Around 25 percent of women with overdose events experienced two to four overdoses, leading to a total of 242 overdose events, 11 of which were fatal, during the study period.

Compared to women with evidence of an opioid use disorder who did not experience an overdose event, those who did experience an overdose were more likely to be younger, single, unemployed, less educated and less likely to have received adequate prenatal care. They were also more likely to have evidence of homelessness or a diagnosis of anxiety or depression. The risk of an overdose event decreased as a pregnancy progressed, reaching its lowest level during the third trimester, but increased during the postpartum period, becoming highest from 7 to 12 months after delivery. In fact, 78 women with no evidence of opioid use disorder during the year before delivery experienced an overdose event during the postpartum period.

Based on insurance claims, prescription records and methadone treatment records, more than 64 percent of women with evidence of an opioid use disorder received some type of medication therapy during the year before delivery. Overall, across the entire study period, overdose rates for women receiving medication therapy were lower than those not receiving treatment.

"The first year postpartum is a particularly vulnerable year for women with opioid use disorder," says Schiff, who is an instructor in Pediatrics at Harvard Medical School. "Factors such as loss of access to specialized care, fragmented transitions from prenatal to postpartum providers, postpartum depression, other psychiatric and homelessness can add to the normal stresses involved with having a new baby. Discontinuing following also may play a role in increased overdose events."

Massachusetts Commissioner of Public Health Monica Bharel, MD, MPH, a co-author of the Obstetrics & Gynecology paper, says that to effectively address the current epidemic it's critical to gain a complete picture of the individuals who are at highest risk. "These findings help expand the lens from which we view the epidemic and allow us to tailor our policies and programs in ways that will increase opportunities for treatment and recovery for these and their children."

Explore further: Methadone and buprenorphine decrease mortality after nonfatal overdose

More information: Davida M. Schiff et al, Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts, Obstetrics & Gynecology (2018). DOI: 10.1097/AOG.0000000000002734

Related Stories

Methadone and buprenorphine decrease mortality after nonfatal overdose

June 19, 2018
A new study out of Boston Medical Center's Grayken Center for Addiction on opioid overdose survivors indicates that two FDA approved medications to treat opioid use disorder save lives, but only three out of 10 overdose survivors ...

Expanding primary care buprenorphine treatment could curb opioid overdose crisis

July 4, 2018
Expanding the availability of medication treatment for opioid use disorder in primary care settings would be a major step toward reducing overdose deaths, write two physicians specializing in addiction medicine and health ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

Older age, ICU, poor renal fcn up risk of opioid OD in hospital

June 13, 2018
(HealthDay)—Risk factors for opioid overdose among hospitalized patients include being age 65 years or older, being in an intensive care unit (ICU), and having renal impairment, according to a study published online May ...

Medicaid patients continue high prescription opioid use after overdose

August 22, 2017
Despite receiving medical attention for an overdose, patients in Pennsylvania Medicaid continued to have persistently high prescription opioid use, with only slight increases in use of medication-assisted treatment, according ...

People with opioid use disorder have high suicide rate

April 26, 2018
(HealthDay)—Patients with opioid use disorder (OUD) seem to have a high rate of suicide, according to a perspective piece published in the April 26 issue of the New England Journal of Medicine.

Recommended for you

Undiagnosed STIs can increase negative PMS symptoms

September 17, 2018
Women that have undiagnosed sexually transmitted infections may be at greater risk of experiencing negative premenstrual symptoms (PMS), according to new Oxford University research.

High dose folic acid does not prevent pre-eclampsia in high risk women

September 13, 2018
Taking high dose folic acid supplements in later pregnancy (beyond the first trimester) does not prevent pre-eclampsia in women at high risk for this condition, finds a randomised controlled trial published by The BMJ today.

Study finds air purifiers may benefit fetal growth

September 12, 2018
A new study led by SFU health sciences researchers Prabjit Barn and Ryan Allen reveals fetal growth may improve if pregnant women use portable air purifiers inside their homes.

Delayed childbearing is a growing source of multiple births, study shows

September 12, 2018
Starting in the 1980s, the number of multiple births—twins, triplets, quadruplets and quintuplets—steadily increased from about 20 sets per 1,000 live births to almost 35 sets per 1,000 live births in the 2010s.

Transforming pregnancy research with a smartphone app

September 5, 2018
For years, pregnant women have been underrepresented in biomedical research. Current treatments, interventions and guidelines do a poor job of taking into consideration the diverse characteristics of all pregnant women.

For women undergoing IVF, is fresh or frozen embryo transfer best?

August 21, 2018
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.